Engineering Iron Oxide Hollow Nanospheres to Enhance Antimicrobial Property: Understanding the Cytotoxic Origin in Organic Rich Environment
Source abstract
Abstract
Engineered magnetic iron oxide nanoparticles with surprisingly high antimicrobial activity and excellent safety profiles to mammalian cell lines have been developed. Hematite hollow nanospheres (HNSs) are prepared by a facile hard templating method; reduction of hematite HNSs by H2 leads to magnetite HNSs. The antimicrobial activity of magnetite HNSs towards Gram negative (Escherichia coli) and Gram positive (Staphylococcus epidermidis) bacteria is evaluated against hematite HNSs and conventional magnetite (C‐magnetite; diameter <50 nm). Superior antibacterial performance is observed for magnetite HNSs towards both E. coli and S. epidermidis over hematite HNSs and C‐magnetite. The origin of the antimicrobial activity of magnetite HNSs is the high leaching of iron ions in the presence of microorganisms, which leads to high generation of reactive oxygen species. Magnetite HNSs allow multiple‐fold increase in the generation of soluble iron ions over hematite HNSs and C‐magnetite, showing that control over both the composition and nanostructure is crucial to tune the antimicrobial activity of iron oxides. Based on the current findings, magnetic HNSs show promising potential antimicrobial applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Iron oxide chemistry and applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Australian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane QLD 4072 Australia
Queensland Alliance for Agriculture and Food Innovation The University of Queensland Brisbane QLD 4072 Australia
References (50)
Show source-provided references
1. 10.1038/nrmicro231910.1038/nrmicro2319 ↗
2. Bonnin L. · 2015
3. European Centre for Disease Prevention and Control · 2009 · 15 · 15
4. 10.2471/BLT.11.08843510.2471/BLT.11.088435 ↗
5. 10.1038/3502120610.1038/35021206 ↗
6. 10.1021/acsami.5b0237410.1021/acsami.5b02374 ↗
7. c)J.O'Neill Report: Review on Antimicrobial Resistance: Tackling a crisis for the health and wealth of nation.2014 http://amr‐review.org/sites/default/files/AMR%20Review%20Paper%20‐%20Tackling%20a%20crisis%20for%20health%20wealth%20of%20nations_1.pdf(accessed Feb 2 2016);
8. d)J. L.Michele Cecchini LukeSlawomirski Antimicrobial Resistance in G7 Countries and Beyond: Economic Issues Policies and Options for Action.2015 https://www.oecd.org/els/health‐systems/Antimicrobial‐Resistance‐in‐G7‐Countries‐and‐Beyond.pdf(accessed Feb 2 2016).
9. 10.1186/s12992-016-0147-y10.1186/s12992-016-0147-y ↗
10. Walsh F. · 2015
11. 10.1126/science.aaa286810.1126/science.aaa2868 ↗
12. 10.1039/C4CC03712J10.1039/C4CC03712J ↗
13. 10.1021/ja035931010.1021/ja0359310 ↗
14. 10.1002/cphc.20120016110.1002/cphc.201200161 ↗
15. 10.1021/nn504262510.1021/nn5042625 ↗
16. 10.1016/j.addr.2013.07.01110.1016/j.addr.2013.07.011 ↗
17. 10.1021/am502642410.1021/am5026424 ↗
18. 10.1038/nrmicro302810.1038/nrmicro3028 ↗
19. 10.1021/jp063826h10.1021/jp063826h ↗
20. 10.1016/j.watres.2008.08.01510.1016/j.watres.2008.08.015 ↗
21. 10.32725/jab.2008.01510.32725/jab.2008.015 ↗
22. 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
23. 10.1021/tx800064j10.1021/tx800064j ↗
24. 10.1021/am303017c10.1021/am303017c ↗
25. 10.2147/IJN.S3534710.2147/IJN.S35347 ↗
26. 10.1021/es102922j10.1021/es102922j ↗
27. 10.1021/nn300934k10.1021/nn300934k ↗
28. 10.1186/1477-3155-9-3410.1186/1477-3155-9-34 ↗
29. Tran N. · Int. J. Nanomed. · 2010 · 5 · 277
30. 10.1038/srep1481310.1038/srep14813 ↗
31. 10.1016/j.biomaterials.2011.03.03910.1016/j.biomaterials.2011.03.039 ↗
32. 10.1016/j.colsurfa.2010.10.01510.1016/j.colsurfa.2010.10.015 ↗
33. 10.1021/nn204118p10.1021/nn204118p ↗
34. 10.1111/j.1753-6405.2008.00173.x10.1111/j.1753-6405.2008.00173.x ↗
35. 10.1002/anie.20100490010.1002/anie.201004900 ↗
36. 10.1039/C5CS00344J10.1039/C5CS00344J ↗
37. 10.1016/j.physb.2006.07.05610.1016/j.physb.2006.07.056 ↗
38. 10.1016/0502-8205(52)90009-910.1016/0502-8205(52)90009-9 ↗
39. 10.1016/j.jcrysgro.2004.05.08110.1016/j.jcrysgro.2004.05.081 ↗
40. 10.1021/la000737210.1021/la0007372 ↗
41. Brandl H. · 2008 · 191
42. 10.1346/CCMN.1981.029040410.1346/CCMN.1981.0290404 ↗
43. 10.1039/c2jm16489b10.1039/c2jm16489b ↗
44. 10.1016/j.saa.2005.05.00210.1016/j.saa.2005.05.002 ↗
45. 10.1146/annurev.micro.57.030502.09093810.1146/annurev.micro.57.030502.090938 ↗
46. 10.1002/smll.20120077210.1002/smll.201200772 ↗
47. 10.1016/j.nano.2007.02.00110.1016/j.nano.2007.02.001 ↗
48. 10.1021/tx800064j10.1021/tx800064j ↗
49. 10.1021/ma302119t10.1021/ma302119t ↗
50. 10.1520/E2149‐13A10.1520/E2149‐13A ↗